- Chemical name: (2α,5α,17β)-2-Methyl-3-oxoandrostan-17-yl propanoate
- Formula: C23H36O3
- Anabolic activity index: 62%
- Androgenic activity index: 25%
PHARMADRO P100 – PHARMACOM LABS
1 vial x 10 ml x 100 mg/ml
Carrier: Grapeseed Oil
PHARMADRO P100 (Drostanolone propionate) stands out as a highly effective option for achieving lean and dense muscles, offering an excellent price-quality ratio. With a relatively short half-life of approximately 1-1.5 days, it is particularly well-suited for shorter and cutting cycles, making it a popular choice among athletes.
Benefits:
- Lean Muscle Development: Ideal for acquiring lean and dense muscle mass.
- Fast-Acting: Short half-life enables quick results, perfect for cutting cycles.
- History and Development: First described in 1959, entered the market in 1970 under the trade name Masteron.
- Anti-Estrogenic Traits: Displays strong anabolic properties with anti-estrogenic characteristics.
- FDA Approval: Approved for treating inoperable breast cancer in climacteric women.
- Muscle Definition: Does not cause water retention, providing improved muscle density, relief, and definition.
- Lipolytic Effect: Facilitates fat reduction, contributing to enhanced muscle condition.
- Bulking Use: While weak as a bulking agent, it offers moderate gains in mass.
- Estrogenic Safety: Does not aromatize, exhibits anti-estrogenic traits, and binds to aromatase.
Side Effects:
- Limited Bulking Effects: Relatively weak for bulking compared to other steroids.
- Condition-Dependent Effects: Most effective when the user is extremely lean.
- Bulking Consideration: May not provide substantial mass gains in a bulking-focused regimen.
Dosage Instructions:
- Cycle Duration: Suitable for shorter cycles due to its fast-acting nature.
- Lean Muscle Focus: Best results achieved when aiming for lean muscle development.
- Cutting Cycle Recommendation: Particularly beneficial for cutting cycles.
- Safe Alternative: Compared to stanozolol, seen as a reasonable and safer option for cutting cycles.
